Low serum zinc is associated with elevated risk of cadmium nephrotoxicity

Environmental Research

Volumn 134, Issue , 2014, Pages 33-38

  Lin, Yu Sheng ^a   Ho, Wen Chao ^b   Caffrey, James L ^c   Sonawane, Babasaheb ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Albuminuria; Cadmium; Glomerular filtration rate; Kidney; Renal; Zinc

Indexed keywords

ALBUMIN; CADMIUM; CREATININE; ZINC;

ABNORMALITY; BIOACCUMULATION; CADMIUM; ECOTOXICOLOGY; HEALTH STATUS; HYPOTHESIS TESTING; NUTRITIONAL STATUS; PHYSIOLOGY; POLLUTION EXPOSURE; PROTEIN; RISK FACTOR; SERUM; TEMPORAL ANALYSIS; URINE; ZINC;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CADMIUM POISONING; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NUTRITIONAL STATUS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; URINE LEVEL; ZINC BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE URINE LEVEL; DEMOGRAPHY; ENVIRONMENTAL EXPOSURE; ETHNICITY; HEALTH CARE SURVEY; PREVALENCE; UNITED STATES; BLOOD; DRUG EFFECTS; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; YOUNG ADULT;

UNITED STATES;

ADULT; AGED; CADMIUM; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT; ZINC;

EID: 84904505258     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2014.06.013     Document Type: Article

References (47)

1. Akesson A., Lundh T., Vahter M., Bjellerup P., Lidfeldt J., Nerbrand C., Samsioe G., Stromberg U., Skerfving S. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ. Health Perspect. 2005, 113:1627-1631.
2. Braga M.M., Dick T., de Oliveira D.L., Guerra A.S., Leite M.C., Ardais A.P., Souza D.O., Rocha J.B. Cd modifies hepatic Zn deposition and modulates delta-ALA-D activity and MT levels by distinct mechanisms. J. Appl. Toxicol. 2012, 32:20-25.
3. Casarett L.J., Klaassen C.D., Watkins J.B. Casarett and Doull's Essentials of Toxicology 2003, 822-827. McGraw-Hill/Medical Pub. Div, New York.
4. Chavers B.M., Simonson J., Michael A.F. A solid phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int. 1984, 25:576-578.
5. Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., Van Lente F., Levey A.S. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047.
6. Edwards J.R., Prozialeck W.C. Cadmium, diabetes and chronic kidney disease. Toxicol. Appl. Pharmacol. 2009, 238:289-293.
7. Fujiwara Y., Lee J.Y., Tokumoto M., Satoh M. Cadmium renal toxicity via apoptotic pathways. Biol. Pharm. Bull. 2012, 35:1892-1897.
8. Hotz C., Peerson J.M., Brown K.H. Suggested lower cutoffs of serum zinc concentrations for assessing zinc status: reanalysis of the second National Health and Nutrition Examination Survey data (1976-1980). Am. J. Clin. Nutr. 2003, 78:756-764.
9. Jacquillet G., Barbier O., Cougnon M., Tauc M., Namorado M.C., Martin D., Reyes J.L., Poujeol P. Zinc protects renal function during cadmium intoxication in the rat. Am. J. Physiol. Renal Physiol. 2006, 290:F127-137.
10. Jemai H., Messaoudi I., Chaouch A., Kerkeni A. Protective effect of zinc supplementation on blood antioxidant defense system in rats exposed to cadmium. J. Trace Elem. Med. Biol. 2007, 21:269-273.
11. Johri N., Jacquillet G., Unwin R. Heavy metal poisoning: the effects of cadmium on the kidney. BioMetals 2010, 23:783-792.
12. Kippler M., Hossain M.B., Lindh C., Moore S.E., Kabir I., Vahter M., Broberg K. Early life low-level cadmium exposure is positively associated with increased oxidative stress. Environ. Res. 2012, 112:164-170.
13. Klaassen C.D., Liu J., Diwan B.A. Metallothionein protection of cadmium toxicity. Toxicol. Appl. Pharmacol. 2009, 238:215-220.
14. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., Kusek J.W., Eggers P., Van Lente F., Greene T., Coresh J., Ckd E.P.I. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009, 150:604-612.
15. Lin Y.S., Rathod D., Ho W.C., Caffrey J.J. Cadmium exposure is associated with elevated blood C-reactive protein and fibrinogen in the U. S. population: the third national health and nutrition examination survey (NHANES III, 1988-1994). Ann. Epidemiol. 2009, 19:592-596.
16. Lin Y.S., Caffrey J.L., Chang M.H., Dowling N., Lin J.W. Cigarette smoking, cadmium exposure, and zinc intake on obstructive lung disorder. Respir. Res. 2010, 11:53.
17. Lin Y.S., Caffrey J.L., Lin J.W., Bayliss D., Faramawi M.F., Bateson T.F., Sonawane B. Increased risk of cancer mortality associated with cadmium exposures in older Americans with low zinc intake. J. Toxicol. Environ. Health A 2013, 76:1-15.
18. Mancia G., Grassi G. Joint national committee VII and European society of hypertension/European society of cardiology guidelines for evaluating and treating hypertension: a two-way road?. J. Am. Soc. Nephrol. 2005, 16(Suppl 1):S74-77.
19. Maret W., Sandstead H.H. Zinc requirements and the risks and benefits of zinc supplementation. J. Trace Elem. Med. Biol. 2006, 20:3-18.
20. Nascetti S., Elosua R., Pena A., Isabel Covas M., Sentí M., Marrugat J. Variables associated with fibrinogen in a population-based study: interaction between smoking and age on fibrinogen concentration. Eur. J. Epidemiol. 2001, 17:953-958.
21. Nordberg G. Handbook on the Toxicology of Metals 2007, Academic Press, Amsterdam; Boston. 3rd ed.
22. Pilch S.M., Senti F.R. Analysis of zinc data from the second National Health and Nutrition Examination Survey (NHANES II). J. Nutr. 1985, 115:1393-1397.
23. Pirkle J.L., Flegal K.M., Bernert J.T., Brody D.J., Etzel R.A., Maurer K.R. Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA 1996, 275:1233-1240.
24. Prasad A.S., Bao B., Beck F.W., Kucuk O., Sarkar F.H. Antioxidant effect of zinc in humans. Free Radic. Biol. Med. 2004, 37:1182-1190.
25. Prasad A.S. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp. Gerontol. 2008, 43:370-377.
26. Sandstead H.H., Prasad A.S., Penland J.G., Beck F.W., Kaplan J., Egger N.G., Alcock N.W., Carroll R.M., Ramanujam V.M., Dayal H.H., Rocco C.D., Plotkin R.A., Zavaleta A.N. Zinc deficiency in Mexican American children: influence of zinc and other micronutrients on T cells, cytokines, and antiinflammatory plasma proteins. Am. J. Clin. Nutr. 2008, 88:1067-1073.
27. Satarug S., Nishijo M., Ujjin P., Vanavanitkun Y., Baker J.R., Moore M.R. Effects of chronic exposure to low-level cadmium on renal tubular function and CYP2A6-mediated coumarin metabolism in healthy human subjects. Toxicol. Lett. 2004, 148:187-197.
28. Satarug S., Nishijo M., Lasker J.M., Edwards R.J., Moore M.R. Kidney dysfunction and hypertension: role for cadmium, p450 and heme oxygenases?. Tohoku J. Exp. Med. 2006, 208:179-202.
29. Satarug S., Garrett S.H., Sens M.A., Sens D.A. Cadmium, environmental exposure, and health outcomes. Environ. Health Perspect. 2010, 118:182-190.
30. Schwartz G.G., Il'yasova D., Ivanova A. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care 2003, 26:468-470.
31. Sethi P.K., Khandelwal D. Cadmium exposure: health hazards of silver cottage industry in developing countries. J. Med. Toxicol. 2006, 2:14-15.
32. Shaikh Z.A., Vu T.T., Zaman K. Oxidative stress as a mechanism of chronic cadmium-induced hepatotoxicity and renal toxicity and protection by antioxidants. Toxicol. Appl. Pharmacol. 1999, 154:256-263.
33. Song Y., Leonard S.W., Traber M.G., Ho E. Zinc deficiency affects DNA damage, oxidative stress, antioxidant defenses, and DNA repair in rats. J. Nutr. 2009, 139:1626-1631.
34. Swaddiwudhipong W., Mahasakpan P., Limpatanachote P., Krintratun S. Correlations of urinary cadmium with hypertension and diabetes in persons living in cadmium-contaminated villages in northwestern Thailand: A population study. Environ. Res. 2010, 110:612-616.
35. Tang W., Sadovic S., Shaikh Z.A. Nephrotoxicity of cadmium-metallothionein: protection by zinc and role of glutathione. Toxicol. Appl. Pharmacol. 1998, 151:276-282.
36. Tapiero H., Tew K.D. Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed. Pharmacother. 2003, 57:399-411.
37. Tellez-Plaza M., Navas-Acien A., Caldwell K.L., Menke A., Muntner P., Guallar E. Reduction in cadmium exposure in the United States population, 1988-2008: the contribution of declining smoking rates. Environ. Health Perspect 2011.
38. Tellez-Plaza M., Navas-Acien A., Crainiceanu C.M., Guallar E. Cadmium exposure and hypertension in the 1999-2004 National Health and Nutrition Examination Survey (NHANES). Environ. Health Perspect. 2008, 116:51-56.
39. Thomas D., Stram D., Dwyer J. Exposure measurement error: influence on exposure-disease relationships and methods of correction. Annu. Rev. Public Health 1993, 14:69-93.
40. U.S. CDC (Centers for Disease Control and Prevention) 2013a. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey 2011-2012: Laboratory Procedures Manual. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Available at: (accessed 01.01.14). http://www.cdc.gov/nchs/about/major/nhanes/lab_methods03_04.htm.
41. U.S. CDC (Centers for Disease Control and Prevention) 2013b. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey 2011-2012: Laboratory Procedures Manual. Analytes: Serum Zinc, Copper and Selenium. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Available at: (accessed 01.01.14). http://www.cdc.gov/nchs/nhanes/nhanes2011-2012/CUSEZN_G.htm%23Component_Description.
42. U.S. CDC (Centers for Disease Control and Prevention) 2014. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey: Analytical Guidelines. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Available at: (accessed 01.01.14). http://www.cdc.gov/nchs/nhanes/analytic_guidelines.htm.
43. van Wijngaarden E., Singer E.A., Palapattu G.S. Prostate-specific antigen levels in relation to cadmium exposure and zinc intake: results from the 2001-2002 National Health and Nutrition Examination Survey. Prostate 2008, 68:122-128.
44. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. Jama 1999, 282:2131-2135.
45. Wessells K.R., Brown K.H. Estimating the global prevalence of zinc deficiency: results based on zinc availability in national food supplies and the prevalence of stunting. PLoS One 2012, 7:e50568.
46. WHO Exposure to cadmium: a major public health concern 2010, World Health Organization, Geneva, Available at: http://www.who.int/ipcs/features/cadmium.pdf (accessed 01.10.14).
47. Yiin S.J., Chern C.L., Sheu J.Y., Tseng W.C., Lin T.H. Cadmium-induced renal lipid peroxidation in rats and protection by selenium. J. Toxicol. Environ. Health A 1999, 57:403-413.